α-Helix-Mimicking Sulfono-γ-AApeptide Inhibitors for p53-MDM2/MDMX Protein-Protein Interactions

被引:53
|
作者
Sang, Peng [4 ]
Shi, Yan [4 ]
Lu, Junhao [3 ]
Chen, Lihong [3 ]
Yang, Leixiang [3 ]
Borcherds, Wade [2 ]
Abdulkadir, Sami [4 ]
Li, Qi [1 ]
Daughdrill, Gary [2 ]
Chen, Jiandong [3 ]
Cai, Jianfeng [4 ]
机构
[1] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Dept Med Oncol, Shanghai 201203, Peoples R China
[2] Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA
[4] Univ S Florida, Dept Chem, Tampa, FL 33620 USA
关键词
AROMATIC OLIGOAMIDE FOLDAMERS; STRUCTURE-BASED DESIGN; BETA(3)-PEPTIDE INHIBITORS; TRANSMEMBRANE PORES; BETA-PEPTIDES; P53; AFFINITY; MIMETICS; MDMX; PEPTOIDS;
D O I
10.1021/acs.jmedchem.9b00993
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The use of peptidomimetic scaffolds is a promising strategy for the inhibition of protein-protein interactions (PPIs). Herein, we demonstrate that sulfono-gamma-AApeptides can be rationally designed to mimic the p53 alpha-helix and inhibit p53 MDM2 PPIs. The best inhibitor, with K-d and IC50 values of 26 nM and 0.891 mu M toward MDM2, respectively, is among the most potent unnatural peptidomimetic inhibitors disrupting the p53-MDM2/MDMX interaction. Using fluorescence polarization assays, circular dichroism, nuclear magnetic resonance spectroscopy, and computational simulations, we demonstrate that sulfono-gamma-AApeptides adopt helical structures resembling p53 and competitively inhibit the p53-MDM2 interaction by binding to the hydrophobic cleft of MDM2. Intriguingly, the stapled sulfono-gamma-AApeptides showed promising cellular activity by enhancing p53 transcriptional activity and inducing expression of MDM2 and p21. Moreover, sulfono-gamma-AApeptides exhibited remarkable resistance to proteolysis, augmenting their biological potential. Our results suggest that sulfono-gamma-AApeptides are a new class of unnatural helical foldamers that disrupt PPIs.
引用
收藏
页码:975 / 986
页数:12
相关论文
共 50 条
  • [21] Profiling inhibitors of MDM2: p53 and MDMX: p53 in relation to MDMX protein levels
    Tudhope, Sue
    Zhao, Yan
    Wittner, Anita
    Wilmore, Elaine
    Bertoli, Annalisa
    Adhikari, Santosh
    Harnor, Suzannah J.
    Del Bello, Fabio
    Piergentili, Alessandro
    Lunec, John
    Hardcastle, Ian R.
    Griffin, Roger J.
    Golding, Bernard R.
    Cano, Celine
    Newell, David R.
    Wedge, Stephen R.
    CANCER RESEARCH, 2014, 74 (19)
  • [22] The p53-MDM2/MDMX axis - A chemotype perspective
    Khoury, Kareem
    Popowicz, Grzegorz M.
    Holak, Tad A.
    Doemling, Alexander
    MEDCHEMCOMM, 2011, 2 (04) : 246 - 260
  • [23] Therapeutic opportunities in cancer therapy: targeting the p53-MDM2/MDMX interactions
    Munisamy, Murali
    Mukherjee, Nayonika
    Thomas, Levin
    Pham, Amy Trinh
    Shakeri, Arash
    Zhao, Yusheng
    Kolesar, Jill
    Rao, Praveen P. N.
    Rangnekar, Vivek M.
    Rao, Mahadev
    AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (12): : 5762 - +
  • [24] Systematic Mutational Analysis of Peptide Inhibition of the p53-MDM2/MDMX Interactions
    Li, Chong
    Pazgier, Marzena
    Li, Changqing
    Yuan, Weirong
    Liu, Min
    Wei, Gang
    Lu, Wei-Yue
    Lu, Wuyuan
    JOURNAL OF MOLECULAR BIOLOGY, 2010, 398 (02) : 200 - 213
  • [25] Comparative study of the p53-mdm2 and p53-MDMX interfaces
    Volker Böttger
    Angelika Böttger
    Carlos Garcia-Echeverria
    Yolande FM Ramos
    Alex J van der Eb
    Aart G Jochemsen
    David P Lane
    Oncogene, 1999, 18 : 189 - 199
  • [26] Comparative study of the p53-mdm2 and p53-MDMX interfaces
    Böttger, V
    Böttger, A
    Garcia-Echeverria, C
    Ramos, YFM
    van der Eb, AJ
    Jochemsen, AG
    Lane, DP
    ONCOGENE, 1999, 18 (01) : 189 - 199
  • [27] Isoindolinone based inhibitors of the MDM2-p53 protein-protein interaction
    Kemp, SJ
    Hardcastle, IR
    Ahmed, SU
    Atatreh, NA
    Barrett, P
    Endicott, JA
    Golding, BT
    Griffin, RJ
    Gruber, J
    Hutton, C
    Lunec, J
    Noble, MEM
    Reid, RJ
    Riedinger, C
    Smyth, LA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2735 - U2736
  • [28] Ensemble-based virtual screening reveals dual-inhibitors for the p53-MDM2/MDMX interactions
    Barakat, Khaled
    Mane, Jonathan
    Friesen, Douglas
    Tuszynski, Jack
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2010, 28 (06): : 555 - 568
  • [29] Discovery, Synthesis, and Biological Evaluation of Orally Active Pyrrolidone Derivatives as Novel Inhibitors of p53-MDM2 Protein-Protein Interaction
    Zhuang, Chunlin
    Miao, Zhenyuan
    Zhu, Lingjian
    Dong, Guoqiang
    Guo, Zizhao
    Wang, Shengzheng
    Zhang, Yongqiang
    Wu, Yuelin
    Yao, Jianzhong
    Sheng, Chunquan
    Zhang, Wannian
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (22) : 9630 - 9642
  • [30] Synthesis and biological evaluation of thio-benzodiazepines as novel small molecule inhibitors of the p53-MDM2 protein-protein interaction
    Zhuang, Chunlin
    Miao, Zhenyuan
    Zhu, Lingjian
    Zhang, Yongqiang
    Guo, Zizhao
    Yao, Jianzhong
    Dong, Guoqiang
    Wang, Shengzheng
    Liu, Yang
    Chen, Hai
    Sheng, Chunquan
    Zhang, Wannian
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2011, 46 (11) : 5654 - 5661